Compare RDIB & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDIB | QSI |
|---|---|---|
| Founded | 1937 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.2M | 273.7M |
| IPO Year | N/A | N/A |
| Metric | RDIB | QSI |
|---|---|---|
| Price | $11.46 | $1.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 6.3K | ★ 5.7M |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $211,292,000.00 | $3,177,000.00 |
| Revenue This Year | $6.85 | N/A |
| Revenue Next Year | $10.86 | $219.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.11 | ★ 40.20 |
| 52 Week Low | $5.78 | $0.95 |
| 52 Week High | $14.95 | $5.77 |
| Indicator | RDIB | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 50.02 | 35.78 |
| Support Level | $10.51 | $1.19 |
| Resistance Level | $12.10 | $1.43 |
| Average True Range (ATR) | 0.45 | 0.11 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 53.35 | 21.18 |
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.